Cite
MLA Citation
PJ Mease et al.. “FRI0511 Secukinumab demonstrates consistent safety over long-term exposure in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses.” Annals of the rheumatic diseases, vol. 76, n.d., p. 683. http://access.bl.uk/ark:/81055/vdc_100135154845.0x000061